SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COMMON STOCK
Total 13F shares
31,701,710
Share change
+7,303,399
Total reported value
$107,169,899
Put/Call ratio
268%
Price per share
$3.38
Number of holders
83
Value change
+$25,585,968
Number of buys
50
Number of sells
35

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2019

As of 31 Dec 2019 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 31,701,710 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Cormorant Asset Management, LP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, D. E. Shaw & Co., Inc., Nuveen Asset Management, LLC, Rubric Capital Management LP, and Bank of New York Mellon Corp.
This table shows 83 institutional shareholders of the security as of 31 Dec 2019.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.